When platelet levels drop, the body’s capacity to clot blood and heal properly starts to falter. Bruising, fatigue, recurring infections, all these can creep in before you even realise something’s ...

Dear Dr. Roach: My husband was diagnosed with chronic lymphocytic leukemia (CLL) in 2010 and remained in stage 2 with no effects until 2022. In the interim, he was also diagnosed with atrial ...

DEAR DR. ROACH: My husband was diagnosed with chronic lymphocytic leukemia (CLL) in 2010 and remained in stage 2 with no effects until 2022. In the interim, he was also diagnosed with atrial ...

What Is the Platelet Aggregation Test? A platelet aggregation test is a blood test that looks at how well your blood cells called platelets clump together and clot. It is sometimes called a platelet ...

CINCINNATI (WKRC) — A cutting-edge procedure is gaining popularity for those seeking to reduce signs of aging on their hands. Dr. Elizabeth Muennich of Dermatology & Skin Care Associates explained the ...

According to the Rhode Island Blood Center, Paul Rego has been a frequent donor at his time in the Ocean State and at his previous home in Pennsylvania. Rego said he was initially inspired to donate ...

Move over, ladies — men are increasingly going under the knife to enhance their looks, ushering in a bold new trend that’s shaking up the aesthetics industry. The American Academy of Facial Plastic ...

Board-certified plastic surgeons make their top trend predictions of 2025, from early intervention procedures to the use of regenerative stem cells, nanofat, exosomes and more. After taking a ...

Platelets (also called thrombocytes) are small blood cell fragments made by your bone marrow. They help form blood clots to stop you from bleeding when you've been injured. Platelets are small cell ...

If you’re someone who stays up to date on the latest skin care procedures and beauty trends, there’s a solid chance you’ve heard of PRP facials by now. Perhaps better known as the “vampire facial,” ...

Takeda may have pruned back the potential indications for mezagitamab, but the latest raft of phase 2 data suggests the anti-CD38 antibody could still “transform treatment” of primary immune ...